Age-dependent association between hepatic lipase gene C-480T polymorphism and the risk of pre-hospital sudden cardiac death: The Helsinki Sudden Death Study

Atherosclerosis

Volumn 192, Issue 2, 2007, Pages 421-427

  Fan, Yue Mei ^a   Lehtimäki, Terho ^a   Rontu, Riikka ^a   Ilveskoski, Erkki ^b   Goebeler, Sirkka ^b   Kajander, Olli ^b   Mikkelsson, Jussi ^b   Perola, Markus ^c   Karhunen, Pekka J ^b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Acute myocardial infarction; Hepatic lipase; Polymorphism; Sudden cardiac death

Indexed keywords

LIVER TRIACYLGLYCEROL LIPASE;

ACUTE HEART INFARCTION; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; AUTOPSY; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; DIABETES MELLITUS; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SMOKING; SUDDEN DEATH;

ADULT; AGED; AUTOPSY; DEATH, SUDDEN, CARDIAC; FINLAND; HUMANS; LIPASE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 34248330038     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.05.028     Document Type: Article

References (44)

1. Epstein S.E., Quyymi A.A., and Bonow R.O. Sudden cardiac death without warning. Possible mechanisms and implications for screening asymptomatic populations. N Engl J Med 321 5 (1989) 320-324
2. Salonen J.T. Primary prevention of sudden coronary death: a community-based program in North Karelia, Finland. Ann N Y Acad Sci 382 (1982) 423-437
3. Friedlander Y., Siscovick D.S., Weinmann S., et al. Family history as a risk factor for primary cardiac arrest. Circulation 97 2 (1998) 155-160
4. Jouven X., Desnos M., Guerot C., and Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation 99 15 (1999) 1978-1983
5. Sanan D.A., Fan J., Bensadoun A., and Taylor J.M. Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J Lipid Res 38 5 (1997) 1002-1013
6. Santamarina-Fojo S., Haudenschild C., and Amar M. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 9 3 (1998) 211-219
7. Gonzalez-Navarro H., Nong Z., Freeman L., Bensadoun A., Peterson K., and Santamarina-Fojo S. Identification of mouse and human macrophages as a site of synthesis of hepatic lipase. J Lipid Res 43 5 (2002) 671-675
8. Nong Z., Gonzalez-Navarro H., Amar M., et al. Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice. J Clin Invest 112 3 (2003) 367-378
9. Dugi K.A., Brandauer K., Schmidt N., et al. Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation 104 25 (2001) 3057-3062
10. Jansen H., Verhoeven A.J., Weeks L., et al. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 17 11 (1997) 2837-2842
11. Tahvanainen E., Syvanne M., Frick M.H., et al. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene The LOCAT Study Invsestigators. J Clin Invest 101 5 (1998) 956-960
12. Deeb S.S., and Peng R. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J Lipid Res 41 1 (2000) 155-158
13. Shohet R.V., Vega G.L., Anwar A., Cigarroa J.E., Grundy S.M., and Cohen J.C. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb Vasc Biol 19 8 (1999) 1975-1978
14. Jansen H., Chu G., Ehnholm C., Dallongeville J., Nicaud V., and Talmud P.J. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B: European Atherosclerosis Research Study (EARS) II. Arterioscler Thromb Vasc Biol 19 2 (1999) 303-308
15. Couture P., Otvos J.D., Cupples L.A., et al. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 20 3 (2000) 815-822
16. Hegele R.A., Harris S.B., Brunt J.H., et al. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations. Atherosclerosis 146 1 (1999) 153-160
17. Murtomaki S., Tahvanainen E., Antikainen M., et al. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler Thromb Vasc Biol 17 10 (1997) 1879-1884
18. Isaacs A., Sayed-Tabatabaei F.A., Njajou O.T., Witteman J.C., and van Duijn C.M. The -514 C→T hepatic lipase promoter region polymorphism and plasma lipids: a meta-analysis. J Clin Endocrinol Metab 89 8 (2004) 3858-3863
19. Andersen R.V., Wittrup H.H., Tybjaerg-Hansen A., Steffensen R., Schnohr P., and Nordestgaard B.G. Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study. J Am Coll Cardiol 41 11 (2003) 1972-1982
20. Ji J., Herbison C.E., Mamotte C.D., Burke V., Taylor R.R., and van Bockxmeer F.M. Hepatic lipase gene -514C/T polymorphism and premature coronary heart disease. J Cardiovasc Risk 9 2 (2002) 105-113
21. Allen A., Belton C., Patterson C., et al. Family-based association studies of lipid gene polymorphisms in coronary artery disease. Am J Cardiol 96 1 (2005) 52-55
22. Peltonen L., Pekkarinen P., and Aaltonen J. Messages from an isolate: lessons from the Finnish gene pool. Biol Chem Hoppe Seyler 376 12 (1995) 697-704
23. Weman S.M., Salminen U.S., Penttila A., Mannikko A., and Karhunen P.J. Post-mortem cast angiography in the diagnostics of graft complications in patients with fatal outcome following coronary artery bypass grafting (CABG). Int J Legal Med 112 2 (1999) 107-114
24. Fan Y., Laaksonen R., Janatuinen T., et al. Hepatic lipase gene variation is related to coronary reactivity in healthy young men. Eur J Clin Invest 31 7 (2001) 574-580
25. Talmud P.J., Hawe E., Robertson K., Miller G.J., Miller N.E., and Humphries S.E. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men. Ann Hum Genet 66 Pt 2 (2002) 111-124
26. Brunzell J.D., and Deeb S.S. Familial lipoprotein lipase deficiency, apoC-II deficiency, and hepatic lipase deficiency. In: Scriver C.R.B.A., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B. (Eds). The metabolic and molecular bases of inherited disease (2001), McGraw-Hill Medical Publishing Company, New York
27. Hegele R.A., Little J.A., Vezina C., et al. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb 13 5 (1993) 720-728
28. Connelly P.W., Maguire G.F., Lee M., and Little J.A. Plasma lipoproteins in familial hepatic lipase deficiency. Arteriosclerosis 10 1 (1990) 40-48
29. Hiserodt J.C., Perper J.A., Koehler S.A., and Orchard T.J. A comparison of blood lipid and lipoprotein values in young adults who die suddenly and unexpectedly from atherosclerotic coronary artery disease with other noncardiac deaths. Am J Forensic Med Pathol 16 2 (1995) 101-106
30. Takeichi S., Nakajima Y., Osawa M., et al. The possible role of remnant-like particles as a risk factor for sudden cardiac death. Int J Legal Med 110 4 (1997) 213-219
31. Fuster V., Badimon L., Badimon J.J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326 5 (1992) 310-318
32. Gomez P., Miranda J.L., Marin C., et al. Influence of the -514C/T polymorphism in the promoter of the hepatic lipase gene on postprandial lipoprotein metabolism. Atherosclerosis 174 1 (2004) 73-79
33. Zambon A., Deeb S.S., Hokanson J.E., Brown B.G., and Brunzell J.D. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 18 11 (1998) 1723-1729
34. Barth J.D., Jansen H., Kromhout D., Reiber J.H., Birkenhager J.C., and Arntzenius A.C. Progression and regression of human coronary atherosclerosis. The role of lipoproteins, lipases and thyroid hormones in coronary lesion growth. Atherosclerosis 68 1-2 (1987) 51-58
35. Groot P.H., van Stiphout W.A., Krauss X.H., et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 11 3 (1991) 653-662
36. Hokanson J.E., Cheng S., Snell-Bergeon J.K., et al. A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes. Diabetes 51 4 (2002) 1208-1213
37. Rundek T., Elkind M.S., Pittman J., et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 33 5 (2002) 1420-1423
38. Faggin E., Zambon A., Puato M., et al. Association between the -514 C→T polymorphism of the hepatic lipase gene promoter and unstable carotid plaque in patients with severe carotid artery stenosis. J Am Coll Cardiol 40 6 (2002) 1059-1066
39. Whiting B.M., Anderson J.L., Muhlestein J.B., et al. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease. Am Heart J 150 2 (2005) 243-250
40. Ordovas J.M., Corella D., Demissie S., et al. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation 106 18 (2002) 2315-2321
41. Tai E.S., Corella D., Deurenberg-Yap M., et al. Dietary fat interacts with the -514C>T polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: the 1998 Singapore National Health Survey. J Nutr 133 11 (2003) 3399-3408
42. Machicao F., Staiger H., Fritsche A., et al. Association of the -514C→T polymorphism in the hepatic lipase gene (LIPC) promoter with elevated fasting insulin concentrations, but not insulin resistance, in non-diabetic Germans. Horm Metab Res 36 5 (2004) 303-306
43. von Eckardstein A., Schulte H., and Assmann G. Increased risk of myocardial infarction in men with both hypertriglyceridemia and elevated HDL cholesterol. Circulation 99 14 (1999) 1925
44. Marenberg M.E., Risch N., Berkman L.F., Floderus B., and de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330 15 (1994) 1041-1046